Cannara Biotech Fiscal Q3 Earnings, Revenue Rise
Cannara Biotech (LOVE.TO) reported fiscal Q3 earnings of C$0.05 per diluted share from C$0.04 a share in the same period a year earlier. Total revenue rose to C$31.8 million in the three months through May 31, compared with C$27.3 million a year ago, the cannabis company said Wednesday. Analysts polled by FactSet expected sales of C$31.2 million.
Story updates
12:31:13 PM UTC
SquawkNews
Earnings Flash (LOVE.TO) Cannara Biotech Reports Q3 Revenue C$31.8M, vs. FactSet Est of C$31.2M
Cannara Biotech (LOVE.TO) reported fiscal Q3 earnings of C$0.05 per diluted share from C$0.04 a share in the same period a year earlier.
Total revenue rose to C$31.8 million in the three months through May 31, compared with C$27.3 million a year ago, the cannabis company said Wednesday.
Analysts polled by FactSet expected sales of C$31.2 million.